Ignite Creation Date:
2025-12-24 @ 9:39 PM
Ignite Modification Date:
2026-01-03 @ 9:23 AM
Study NCT ID:
NCT03954132
Status:
COMPLETED
Last Update Posted:
2024-04-24
First Post:
2019-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pulmonary Disease, Chronic Obstructive | View |
Keywords: